Navigation Links
Bernstein Liebhard LLP Launches New Transvaginal Mesh Lawsuit Website for Women Allegedly Injured by Pelvic Mesh Implants

New York, NY (PRWEB) October 26, 2013

Bernstein Liebhard LLP has launched a new transvaginal mesh lawsuit website ( ) for women seeking legal help after allegedly suffering infection, vaginal scarring and other debilitating injuries caused by pelvic mesh implants. In addition to providing the most up-to-date information about side effects, mesh removal surgery, and products now at the center of fast-developing vaginal mesh lawsuit litigations, the Firm’s recently-unveiled website also provides detailed instruction on how to file a claim.

If you sustained any of the following injuries following implantation of pelvic mesh to treat stress urinary incontinence or pelvic organ prolapse, you may also contact a transvaginal mesh lawyer at the Firm to receive a free and confidential evaluation of your potential case:

  •     Pain during sexual intercourse
  •     Infection
  •     Chronic Pain
  •     Urinary problems
  •     Recurrence of pelvic organ prolapse or incontinence
  •     Bladder, blood vessel and bowel perforation
  •     Vaginal scarring

“As we continue to hear from women who allegedly sustained the painful and debilitating complications associated with pelvic mesh, the information on our new website will be vital to women seeking to file transvaginal mesh lawsuits against the makers of these products,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices.

Transvaginal Mesh Lawsuits
According to recent court records, at least 30,000 vaginal mesh lawsuits have been filed in the U.S. on behalf of women allegedly injured by pelvic mesh implants. Many of these cases are currently pending in separate federal multidistrict litigations underway in the U.S. District Court, Southern District of West Virginia over products manufactured by C.R. Bard Inc., American Medical Systems Inc., the Johnson & Johnson subsidiary, Ethicon Inc., Boston Scientific Corp., and other companies. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is currently a member of the Plaintiffs’ Steering Committees for the following four federal proceedings: American Medical Systems (MDL No. 2325), Boston Scientific Corp., (MDL No. 2326); C.R. Bard, Inc., (MDL No. 2187), and Ethicon, Inc. (MDL No. 2327).

In New Jersey’s Atlantic County Superior Court, Mr. Grand is also serving as Co-Liaison Counsel in two separate consolidated litigations established for lawsuits that allege injuries caused by pelvic mesh manufactured by Ethicon and C.R. Bard Inc. He was also an active member of the trial team in the Ethicon proceeding’s first trial, which concluded in March with an $11 million damage award to the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

The U.S. Food and Drug Administration (FDA) issued its first official vaginal mesh side effects warning in 2008, citing mesh erosion, organ damage, chronic infections and shrinkage as the most commonly reported transvaginal mesh complications.* At the time, the frequency for these injuries to occur was classified as “rare,” a stance the agency upgraded to “not rare” in 2011 after the number of FDA-filed complaint reports dramatically increased over a three-year period.

If you experienced pain during sexual intercourse, chronic infection, vaginal scarring or another injury after receiving a transvaginal mesh implant, you may be eligible to collect compensation for lost wages, out-of-pocket medical expenses, and other damages. Learn more about mesh erosion and other complications associated with pelvic mesh by visiting Bernstein Liebhard LLP’s new website. You may also call the following toll-free number to speak with a lawyer directly: 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. U.S. Federal Panel Vacates Order to Transfer Mirena Lawsuit to New York Litigation, Bernstein Liebhard LLP Reports
2. New Risperdal Lawsuit Filed in Pennsylvania Litigation; Alleges Male Breast Growth Injuries Caused by Anti-Psychotic Medication, Bernstein Liebhard LLP Reports
3. Wright Hip Lawsuit News: Federal Judge Allows Certain Claims to Proceed in Wright Profemur Hip Replacement Lawsuit, Bernstein Liebhard LLP Reports
4. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Judge’s Decision to Uphold Verdict in First Federal Trial of C.R. Bard Vaginal Mesh Lawsuit
5. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of Da Vinci Surgery Lawsuit Filings
6. Bernstein Liebhard LLP Investigating Risperdal Lawsuits on Behalf of Victims of Male Breast Growth Allegedly Caused by Risperdal
7. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in Federal Biomet Hip Replacement Litigation
8. Actos Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in Federal Actos Litigation
9. Stryker Hip Lawsuits Progress in State, Federal Stryker Hip Recall Litigations, Bernstein Liebhard LLP Reports
10. Mirena Lawsuits Progress in State, Federal Litigations, Bernstein Liebhard LLP Reports
11. Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Discovery Conferences in Federal Vaginal Mesh Litigation, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: